University Putra Malaysia   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Serdang Malaysia (1931)

Organization Overview

First Clinical Trial
2009
NCT01086488
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dr. Tikfu Gee | HospitalPutrajaya | Nutrition and Dietetic department, University Putra Malaysia | Putrajaya Hospital, Malaysia | Putra Medical Centre, Malaysia | Universiti Putra Malaysia | University Putra Malaysia | UPM

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Graves Disease (Phase 3)

Hyperthyroidism (Phase 3)

Lipid Metabolism Disorders (Phase 2)

Metabolic Diseases (Phase 2)

Metabolic Syndrome (Phase 2)

Nasopharyngeal Carcinoma (Phase 2)

Obesity, Abdominal (Phase 2)

Vitamin D Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 17